| Date | Form | Description | Docs | XBRL | Pages |
| 02/23/00 | S-8 POS | Post-effective amendment to a S-8 registration statement |
|
9 | |
| 01/28/00 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
60 | |
| 09/13/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 07/28/99 | 8-K | Current report filing |
|
10 | |
| 06/28/99 | DEF 14A | Definitive proxy statements |
|
9 | |
| 06/17/99 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
6 | |
| 06/14/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
25 | |
| 03/31/99 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
13 | |
| 03/16/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 | |
| 01/29/99 | 10-K405 | Annual report [Sections 13 and 15(d), S-K Item 405] |
|
42 |
Latest News & Events
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
Read More...